Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200586579> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4200586579 endingPage "800" @default.
- W4200586579 startingPage "794" @default.
- W4200586579 abstract "Sunitinib has been approved for the treatment of pancreatic neuroendocrine tumors, renal-cell carcinoma, and gastrointestinal stromal tumors. The elevation of thyroid-stimulating hormone serum levels is a common side effect. Studies suggest a correlation between sunitinib-induced hypothyroidism and treatment outcome in patients with renal-cell carcinoma and gastrointestinal stromal tumors. This study assessed whether sunitinib-induced hypothyroidism is a predictive marker of the objective response rate, progression-free survival, and overall survival in pancreatic neuroendocrine tumor patients. Twenty-nine patients treated with sunitinib for advanced pancreatic neuroendocrine tumors were included. The incidence of sunitinib-induced hypothyroidism was 33%. The median progression-free survival of patients who developed hypothyroidism was 16 months (95% confidence interval: 6.2-25.8 months) as compared with six months among euthyroid patients (95% confidence interval: 0.1-12.2 months) (p=0.02). The median overall survival was 77 months (95% confidence interval: 31.4-122.6 months) in hypothyroid patients but 12 months (95% confidence interval: 5.9-18.1 months) in subjects with euthyroidism (p=0.001). The median overall survival from the time of initial diagnosis ranged from 247 months in patients with hypothyroidism to 65 months in euthyroid subjects (p=0.015). Elevated thyroid-stimulating hormone levels are a prognostic biomarker of improved outcomes of sunitinib therapy in pancreatic neuroendocrine tumor patients." @default.
- W4200586579 created "2021-12-31" @default.
- W4200586579 creator A5014472885 @default.
- W4200586579 creator A5026996845 @default.
- W4200586579 creator A5077613551 @default.
- W4200586579 date "2021-12-01" @default.
- W4200586579 modified "2023-10-15" @default.
- W4200586579 title "Sunitinib-Induced Hypothyroidism and Survival in Pancreatic Neuroendocrine Tumors" @default.
- W4200586579 cites W1898278836 @default.
- W4200586579 cites W1933440621 @default.
- W4200586579 cites W1998151526 @default.
- W4200586579 cites W2003971943 @default.
- W4200586579 cites W2048404979 @default.
- W4200586579 cites W2051963942 @default.
- W4200586579 cites W2057767062 @default.
- W4200586579 cites W2091983653 @default.
- W4200586579 cites W2097535250 @default.
- W4200586579 cites W2140794446 @default.
- W4200586579 cites W2148356480 @default.
- W4200586579 cites W2149267995 @default.
- W4200586579 cites W2154117685 @default.
- W4200586579 cites W2154160889 @default.
- W4200586579 cites W2158474413 @default.
- W4200586579 cites W2225295951 @default.
- W4200586579 cites W2525361705 @default.
- W4200586579 cites W2530107877 @default.
- W4200586579 cites W2598071289 @default.
- W4200586579 cites W2608160487 @default.
- W4200586579 cites W2922920959 @default.
- W4200586579 cites W2947336601 @default.
- W4200586579 cites W4210985377 @default.
- W4200586579 doi "https://doi.org/10.1055/a-1658-3077" @default.
- W4200586579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34891209" @default.
- W4200586579 hasPublicationYear "2021" @default.
- W4200586579 type Work @default.
- W4200586579 citedByCount "7" @default.
- W4200586579 countsByYear W42005865792022 @default.
- W4200586579 countsByYear W42005865792023 @default.
- W4200586579 crossrefType "journal-article" @default.
- W4200586579 hasAuthorship W4200586579A5014472885 @default.
- W4200586579 hasAuthorship W4200586579A5026996845 @default.
- W4200586579 hasAuthorship W4200586579A5077613551 @default.
- W4200586579 hasBestOaLocation W42005865791 @default.
- W4200586579 hasConcept C126322002 @default.
- W4200586579 hasConcept C134018914 @default.
- W4200586579 hasConcept C2777195454 @default.
- W4200586579 hasConcept C2777472916 @default.
- W4200586579 hasConcept C2779066768 @default.
- W4200586579 hasConcept C2779490328 @default.
- W4200586579 hasConcept C44249647 @default.
- W4200586579 hasConcept C526584372 @default.
- W4200586579 hasConcept C71924100 @default.
- W4200586579 hasConcept C90924648 @default.
- W4200586579 hasConceptScore W4200586579C126322002 @default.
- W4200586579 hasConceptScore W4200586579C134018914 @default.
- W4200586579 hasConceptScore W4200586579C2777195454 @default.
- W4200586579 hasConceptScore W4200586579C2777472916 @default.
- W4200586579 hasConceptScore W4200586579C2779066768 @default.
- W4200586579 hasConceptScore W4200586579C2779490328 @default.
- W4200586579 hasConceptScore W4200586579C44249647 @default.
- W4200586579 hasConceptScore W4200586579C526584372 @default.
- W4200586579 hasConceptScore W4200586579C71924100 @default.
- W4200586579 hasConceptScore W4200586579C90924648 @default.
- W4200586579 hasIssue "12" @default.
- W4200586579 hasLocation W42005865791 @default.
- W4200586579 hasLocation W42005865792 @default.
- W4200586579 hasOpenAccess W4200586579 @default.
- W4200586579 hasPrimaryLocation W42005865791 @default.
- W4200586579 hasRelatedWork W1748917316 @default.
- W4200586579 hasRelatedWork W1931475962 @default.
- W4200586579 hasRelatedWork W2011407321 @default.
- W4200586579 hasRelatedWork W2027281830 @default.
- W4200586579 hasRelatedWork W2075668427 @default.
- W4200586579 hasRelatedWork W2106908546 @default.
- W4200586579 hasRelatedWork W2377837277 @default.
- W4200586579 hasRelatedWork W2605213934 @default.
- W4200586579 hasRelatedWork W3133628686 @default.
- W4200586579 hasRelatedWork W4210761006 @default.
- W4200586579 hasVolume "53" @default.
- W4200586579 isParatext "false" @default.
- W4200586579 isRetracted "false" @default.
- W4200586579 workType "article" @default.